REGENXBIO

REGENXBIO RGNX Stock

$7.16   -0.278551%
Add to favorites
Market Cap
$473.44M
LOW - HIGH [24H]
$6.86 - $7.30
VOLUME [24H]
$1.05M
P/E Ratio
0
Earnings per share
-$3.20
ISIN
US75901B1070
Price   Prediction

REGENXBIO Price Chart

Sorry, that's all we've gotfor now...

REGENXBIO (RGNX) stock price today is 7.16 USD on Tech Market Large (-0.28% on the day). Updated .

REGENXBIO RGNX Financial and Trading Overview

REGENXBIO stock price 7.16 USD
Previous Close 7.18 USD
Open 7 USD
Bid 5.15 USD x 200
Ask 8.96 USD x 200
Day's Range 6.86 - 7.3 USD
52 Week Range 5.46 - 16.19 USD
Volume 1.05M USD
Avg. Volume 1.39M USD
Market Cap 473.44M USD
Beta (5Y Monthly) 1.228
PE Ratio (TTM) N/A
EPS (TTM) -3.2 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 21.4 USD

RGNX Valuation Measures

Enterprise Value 474.69M USD
Trailing P/E N/A
Forward P/E -2.3196518
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.0760489
Price/Book (mrq) 3.197856
Enterprise Value/Revenue 3.084
Enterprise Value/EBITDA -2.787

Trading Information

REGENXBIO Stock Price History

Beta (5Y Monthly) 1.228
52-Week Change -39.15%
S&P500 52-Week Change 8.67%
52 Week High 16.19 USD
52 Week Low 5.46 USD
50-Day Moving Average 7.54 USD
200-Day Moving Average 8.8 USD

RGNX Share Statistics

Avg. Volume (3 month) 1.39M USD
Avg. Daily Volume (10-Days) 1.17M USD
Shares Outstanding 66.12M
Float 56.63M
Short Ratio 7.27
% Held by Insiders 6.50%
% Held by Institutions 82.81%
Shares Short 10.18M
Short % of Float 16.29%
Short % of Shares Outstanding 15.40%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -113.85%
Operating Margin (ttm) -120.39%
Gross Margin -64.53%
EBITDA Margin -110.64%

Management Effectiveness

Return on Assets (ttm) -23.36%
Return on Equity (ttm) -113.23%

Income Statement

Revenue (ttm) 153.91M USD
Revenue Per Share (ttm) 2.77 USD
Quarterly Revenue Growth (yoy) -69.19%
Gross Profit (ttm) -99319000 USD
EBITDA -170296992 USD
Net Income Avi to Common (ttm) -175228992 USD
Diluted EPS (ttm) -3.2
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 250.98M USD
Total Cash Per Share (mrq) 3.8 USD
Total Debt (mrq) 252.22M USD
Total Debt/Equity (mrq) 170.37 USD
Current Ratio (mrq) 4.741
Book Value Per Share (mrq) 2.239

Cash Flow Statement

Operating Cash Flow (ttm) -152104992 USD
Levered Free Cash Flow (ttm) -128852000 USD

Profile of REGENXBIO

Country United States
State MD
City Rockville
Address 9804 Medical Center Drive
ZIP 20850
Phone 240 552 8181
Website https://www.regenxbio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 371

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

Q&A For REGENXBIO Stock

What is a current RGNX stock price?

REGENXBIO RGNX stock price today per share is 7.16 USD.

How to purchase REGENXBIO stock?

You can buy RGNX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for REGENXBIO?

The stock symbol or ticker of REGENXBIO is RGNX.

Which industry does the REGENXBIO company belong to?

The REGENXBIO industry is Biotechnology.

How many shares does REGENXBIO have in circulation?

The max supply of REGENXBIO shares is 66.12M.

What is REGENXBIO Price to Earnings Ratio (PE Ratio)?

REGENXBIO PE Ratio is now.

What was REGENXBIO earnings per share over the trailing 12 months (TTM)?

REGENXBIO EPS is -3.2 USD over the trailing 12 months.

Which sector does the REGENXBIO company belong to?

The REGENXBIO sector is Healthcare.

REGENXBIO RGNX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Composite Total Return XCMP US 27958.09 USD —
-5.28
— — 27828.65 USD — 29466.09 USD — — — —
us US Tech Global Select Market Com NQGS US 11139.01 USD —
-5.31
— — 11086.73 USD — 11742.47 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech US 700 Small Cap Index NQUS700SC US 2801.87 USD —
-2.68
— — 2797.1 USD — 2892.69 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3419.87 USD —
-3.87
— — 3408.51 USD — 3548.76 USD — — — —
us US Tech Biotechnology NBI US 6781.89 USD —
-1.73
— — 6767.31 USD — 6980.47 USD — — — —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
$2.08T
Total marketcap
$131.4B
Total volume
BTC 57.90%   •   ETH 9.85%
Dominance
Select currency